假体周围关节感染的新兴技术:新兴诊断方法
本文综述假体周围关节感染(PJI)的新兴诊断策略,包括基于X射线的关节内pH实时监测传感器、尿液肽类生物标志物、分子与免疫细胞谱分析及先进滑液检测;滑液钙卫蛋白经侧向层析法快速检测,在区分PJI与无菌性失败中显示高灵敏度和特异度,但作者指出尚需大规模临床验证才能将这些创新确立为标准诊疗工具。
要点
- 滑液钙卫蛋白经侧向层析法快速检测,在区分PJI与无菌性失败中显示高灵敏度和特异度。
- 基于X射线的植入式pH传感器可无创监测滑膜环境变化,有助于更早发现感染。
- 尿液肽类生物标志物与多组学技术为PJI诊断提供新的非侵入性或高精度途径。
核心结论
- 这些新兴诊断技术的整合有望革新PJI检测,减少诊断延迟和不必要的侵入性操作,但尚需大规模临床验证才能将其确立为标准诊疗工具。
研究设计与样本
- 本文为综述,探讨PJI的新兴诊断策略,包括基于X射线的关节内pH实时监测传感器、尿液肽类生物标志物、分子与免疫细胞谱分析及先进滑液检测。
主要发现
- 植入式pH传感器与X射线激发发光化学成像可无创监测滑膜环境变化,从而更早发现感染。
- 尿液肽类生物标志物提供反映PJI相关全身炎症反应的新型非侵入性途径。
- 多组学技术(转录组、蛋白质组和免疫细胞谱分析)可深入揭示宿主-病原体相互作用,高精度区分PJI与无菌性失败。
- 滑液钙卫蛋白由中性粒细胞和巨噬细胞释放,经侧向层析法快速检测,在区分PJI与无菌性失败中显示高灵敏度和特异度。
- 近期研究在术中与门诊环境中验证了滑液钙卫蛋白的临床实用性,其诊断性能与既定标准相当。
临床怎么用
- 作者指出,这些新兴诊断技术的整合有望革新PJI检测,减少诊断延迟和不必要的侵入性操作,但尚需大规模临床验证才能确立为标准诊疗工具。
局限性
- 作者指出,尚需大规模临床验证才能将这些创新确立为标准诊疗工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periprosthetic joint infection (PJI) is one of the most challenging complications following total joint arthroplasty, contributing to high morbidity, increased health care costs, and frequent implant failures. The current diagnostic methods, including synovial fluid analysis and microbiological cultures, are limited by their sensitivity and specificity, particularly in culture-negative infections. As a result, there is a growing need for novel diagnostic technologies that can provide rapid and reliable detection of PJI. This review explores emerging diagnostic strategies, including real-time intra-articular pH monitoring via X-ray-based sensors, urinary peptide biomarkers, molecular and immune cell profiling, and advanced synovial fluid assays. Implantable pH sensors and X-ray-excited luminescence chemical imaging allow noninvasive monitoring of synovial environment changes, enabling earlier infection detection. Urinary peptide biomarkers provide a novel, noninvasive approach, reflecting systemic inflammatory responses associated with PJI. Multiomic techniques, including transcriptomic, proteomic, and immune cell profiling, offer deeper insights into host-pathogen interactions, distinguishing PJI from aseptic failures with high accuracy. Among synovial fluid biomarkers, calprotectin has gained major attention due to its rapid detection capabilities via a lateral flow assay. As a proinflammatory protein released by neutrophils and macrophages, synovial calprotectin demonstrates high sensitivity and specificity in differentiating PJI from aseptic failures, making it an effective point-of-care diagnostic tool. Recent studies have validated its clinical utility in intraoperative and outpatient settings, with strong diagnostic performance comparable to established criteria. The integration of these novel diagnostic technologies has the potential to revolutionize PJI detection, reducing diagnostic delays and unnecessary invasive procedures. However, further large-scale clinical validation is required to establish these innovations as standard-of-care tools, ultimately improving patient outcomes and prosthetic longevity.
引用
- Magruder ML, Heckmann ND, Lieberman JR, et al. Novel Technologies in Periprosthetic Joint Infection: Emerging Diagnostics. J Arthroplasty. 2025. PMID: 40782944. doi:10.1016/j.arth.2025.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。